Psychological Trauma: Theory, Research, Practice and Policy
October 31, 2024
Caitlin L Mclean, Ashley Faytol, Gage Chu et al.
1 citation
While mobile delivery can help increase access to evidence-based treatment for veterans with posttraumatic stress disorder (PTSD), feasibility and acceptability are of concern with the potential for high attrition rates and limited participation. The Mantram Repetition Program (MRP), a meditation-focused approach with documented efficacy for reducing symptoms of PTSD and insomnia, was adapted...
Primenjena psihologija
October 30, 2024
Sonja Protic, Robert-Jacek Gorzka, Helge Höllmer et al.
Introduction: The role of neuroticism in the relationship between nightmare characteristics (e.g., frequency and replicativity), and nightmare-related suffering, i.e., nightmare-related distress and impairment after awaking, is still to be explored. Methods: In a sample of 346 soldiers (mean age 33.95 years, 13.9% females) who experienced at least one traumatic event (47.0% having a formal...
Psychiatry Research
October 11, 2024
Robert Dudley, Sarah White, Rebecca Miskin et al.
4 citations
Auditory hallucinations are common in people with histories of adversity, possibly indicating a causal relationship. However, hallucinations occur in multiple sensory modalities and the relationship between trauma and hallucinations in other sensory domains is less explored. We examined the occurrence of hallucinatory experiences in different sensory modalities in people with psychosis who also...
European Journal of Psychotraumatology
October 8, 2024
Anthony N Reffi, Philip Cheng, David A Kalmbach et al.
ABSTRACT Background: Research suggests trauma-related nightmares (TRNs) during the acute aftermath of trauma may contribute to posttraumatic stress disorder (PTSD). However, it is unknown who is most vulnerable to TRNs, which is critical to identify at-risk patients toward whom early nightmare-focused treatments can be targeted to prevent PTSD. Objective: We tested trauma type (interpersonal...
Journal of Psychopharmacology
October 3, 2024
Charles Q. Choi, Danica E. Johnson, David C J Chen-Li et al.
11 citations
Posttraumatic stress disorder (PTSD) is a condition that can develop after a traumatic event, causing distressing symptoms, including intrusive re-experiencing symptoms, alterations in mood and cognition, and changes in arousal and reactivity. Few treatment options exist for patients who find conventional psychotherapy and pharmacotherapy to be inaccessible, ineffective, or intolerable. We...
Psychiatry Research
October 1, 2024
Seyed Aria Nejadghaderi, Seyed Ehsan Mousavi, Asra Fazlollahi et al.
11 citations
Yoga is an increasingly popular complementary intervention to reduce posttraumatic stress disorder (PTSD) symptoms and related comorbidities, but its safety and treatment efficacy are not firmly established. We conducted a systematic review and meta-analysis of existing randomized control trials (RCTs) of yoga interventions for PTSD and related secondary outcomes (e.g., depression). Initial...
Journal of Integrative and Complementary Medicine
October 1, 2024
Skylar Kelsven, Caitlin L Mclean, Kiara Widjanarko et al.
3 citations
Objectives: This secondary analysis examined five facets of mindful awareness as potential moderators of clinical outcomes using data from a randomized controlled trial (RCT) that compared Mantram Repetition Program (MRP) with present-centered therapy (PCT) in veterans with post-traumatic stress disorder (PTSD). Methods: Data were examined from 173 veterans with military-related PTSD randomly...
Journal of Psychiatric Research
October 1, 2024
Zixun Wang, Xinyu Hu, Zhongyi Wang et al.
9 citations
Each year, 3-4% of the global population experiences post-traumatic stress disorder (PTSD), a chronic mental disorder with significant social and economic repercussions. Although it has been shown that ketamine can effectively alleviate PTSD symptoms in individuals, the specific mechanism of action underlying its anti-PTSD effects remains unclear. In this study, we investigated how a single,...
Contemporary Clinical Trials Communications
October 1, 2024
Erica Eaton, Christy Capone, Brian J Gully et al.
2 citations
Posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) commonly co-occur and are associated with more severe symptomatology than either disorder alone, increased risk of suicide, and poorer response to existing treatments. A promising therapeutic intervention is the integration of 3,4-methylenedioxymethamphetamine (MDMA) and psychotherapy. The Food and Drug Administration (FDA)...
Neurorehabilitation
September 27, 2024
Walter Dunn, Anya K. Bershad, David E. Krantz et al.
2 citations
BACKGROUND: Neurorehabilitation in military populations is complicated by higher rates of PTSD and unique characteristics of military institutions. These factors can adversely impact the patient-therapist therapeutic alliance and engagement with the rehabilitation process leading to poorer outcomes. MDMA is a non-classical psychedelic with pro-social and fear regulating properties....